Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuron (IMRN) Liabilities and Shareholders Equity (2017 - 2025)

Immuron (IMRN) has 9 years of Liabilities and Shareholders Equity data on record, last reported at $6.5 million in Q2 2025.

  • For Q2 2025, Liabilities and Shareholders Equity fell 36.69% year-over-year to $6.5 million; the TTM value through Jun 2025 reached $49.2 million, down 22.56%, while the annual FY2025 figure was $6.6 million, 35.62% down from the prior year.
  • Liabilities and Shareholders Equity reached $6.5 million in Q2 2025 per IMRN's latest filing, down from $10.2 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $20.8 million in Q2 2021 and bottomed at $6.5 million in Q2 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $14.0 million, with a median of $14.7 million recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 412.48% in 2021, then crashed 36.69% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $20.8 million in 2021, then fell by 14.54% to $17.8 million in 2022, then decreased by 17.45% to $14.7 million in 2023, then crashed by 30.27% to $10.2 million in 2024, then tumbled by 36.69% to $6.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $6.5 million in Q2 2025, $10.2 million in Q2 2024, and $14.7 million in Q2 2023.